Document is current
Any future updates will be listed below
-
Authors
Gupta, Brinda
Borghaei, Leila
Liu, Stephen V.
- License Information
-
More Information
Article History
Accepted: 15 January 2025
First Online: 31 January 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Brinda Gupta and Leila Borghaei declare no conflict of interest. Stephen V. Liu has received research funding (to institution) from Abbvie, Alkermes, AstraZeneca, Bristol-Myers Squibb, Cogent Biosciences, Duality, Elevation Oncology, Ellipses, Genentech, Gilead, Merck, Merus, Nuvalent, OSE Immunotherapeutics, Puma, RAPT, Synthekine, and SystImmune; and has received compensation for participation on an advisory board or as a consultant from Abbvie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Genentech/Roche, Gilead, GSK, Guardant Health, Johnson & Johnson, Jazz Pharmaceuticals, Lilly, Merck, Merus, Mirati, Natera, Novartis, OSE Immunotherapeutics, Pfizer, Regeneron, Revolution Medicines, Takeda, and Yuhan.
